

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.78539939 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.78539939 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.52290579 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 4.93026487 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.75055534 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.64486151 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.64486151 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.33006057 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.32802965 |
| 10 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.28450510 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.24975476 |
| 12 | DNA deamination (GO:0045006) | 4.24394973 |
| 13 | viral transcription (GO:0019083) | 3.77067002 |
| 14 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.76602252 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.74641227 |
| 16 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.74563095 |
| 17 | regulation of mast cell degranulation (GO:0043304) | 3.73391665 |
| 18 | thrombin receptor signaling pathway (GO:0070493) | 3.64317296 |
| 19 | positive regulation of mast cell activation (GO:0033005) | 3.64292455 |
| 20 | translational termination (GO:0006415) | 3.62098619 |
| 21 | protein targeting to ER (GO:0045047) | 3.61965416 |
| 22 | cotranslational protein targeting to membrane (GO:0006613) | 3.61137198 |
| 23 | neutrophil activation (GO:0042119) | 3.60115365 |
| 24 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.57507627 |
| 25 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.57507627 |
| 26 | Golgi transport vesicle coating (GO:0048200) | 3.56091532 |
| 27 | COPI coating of Golgi vesicle (GO:0048205) | 3.56091532 |
| 28 | regulation of mast cell activation (GO:0033003) | 3.55716023 |
| 29 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.55076602 |
| 30 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.49965067 |
| 31 | protein localization to endoplasmic reticulum (GO:0070972) | 3.46932290 |
| 32 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.46170036 |
| 33 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.42604204 |
| 34 | granulocyte activation (GO:0036230) | 3.40500690 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 3.34664546 |
| 36 | translational elongation (GO:0006414) | 3.33144560 |
| 37 | positive regulation by symbiont of host defense response (GO:0052509) | 3.30526355 |
| 38 | modulation by symbiont of host defense response (GO:0052031) | 3.30526355 |
| 39 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.30526355 |
| 40 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.30526355 |
| 41 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.30526355 |
| 42 | modulation by symbiont of host immune response (GO:0052553) | 3.30526355 |
| 43 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.28079247 |
| 44 | leukocyte degranulation (GO:0043299) | 3.25401569 |
| 45 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.25153403 |
| 46 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.24323704 |
| 47 | response to interferon-beta (GO:0035456) | 3.24140907 |
| 48 | detection of other organism (GO:0098543) | 3.17170294 |
| 49 | positive regulation of interleukin-17 production (GO:0032740) | 3.16336055 |
| 50 | cellular extravasation (GO:0045123) | 3.15298917 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.14143416 |
| 52 | detection of bacterium (GO:0016045) | 3.13040431 |
| 53 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.12290672 |
| 54 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.11705014 |
| 55 | myeloid cell activation involved in immune response (GO:0002275) | 3.11695117 |
| 56 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.11057881 |
| 57 | regulation of platelet aggregation (GO:0090330) | 3.11022357 |
| 58 | response to peptidoglycan (GO:0032494) | 3.07939087 |
| 59 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.07624626 |
| 60 | response to interleukin-15 (GO:0070672) | 3.07215043 |
| 61 | regulation of leukocyte degranulation (GO:0043300) | 3.06233060 |
| 62 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.05616131 |
| 63 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.04084507 |
| 64 | regulation of platelet activation (GO:0010543) | 3.02751523 |
| 65 | signal peptide processing (GO:0006465) | 3.02013301 |
| 66 | respiratory burst (GO:0045730) | 3.01101707 |
| 67 | ribosomal small subunit biogenesis (GO:0042274) | 2.94554958 |
| 68 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.91492402 |
| 69 | positive regulation of mast cell degranulation (GO:0043306) | 2.91492402 |
| 70 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.91312744 |
| 71 | interferon-gamma production (GO:0032609) | 2.90995894 |
| 72 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.88319479 |
| 73 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.87079908 |
| 74 | viral life cycle (GO:0019058) | 2.86702368 |
| 75 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.84206441 |
| 76 | negative regulation of T cell apoptotic process (GO:0070233) | 2.84116484 |
| 77 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.84081607 |
| 78 | megakaryocyte development (GO:0035855) | 2.81397967 |
| 79 | positive regulation of B cell differentiation (GO:0045579) | 2.79481024 |
| 80 | cellular response to interleukin-15 (GO:0071350) | 2.78968341 |
| 81 | regulation of interleukin-17 production (GO:0032660) | 2.78235700 |
| 82 | positive thymic T cell selection (GO:0045059) | 2.77178590 |
| 83 | lipoxygenase pathway (GO:0019372) | 2.75999384 |
| 84 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.75967439 |
| 85 | translational initiation (GO:0006413) | 2.75768284 |
| 86 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.74788712 |
| 87 | mature B cell differentiation involved in immune response (GO:0002313) | 2.74538330 |
| 88 | autophagic vacuole fusion (GO:0000046) | 2.73264180 |
| 89 | protein retention in ER lumen (GO:0006621) | 2.71896875 |
| 90 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.70605217 |
| 91 | formation of translation preinitiation complex (GO:0001731) | 2.70205869 |
| 92 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.69316947 |
| 93 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.69278406 |
| 94 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.67940222 |
| 95 | negative regulation of innate immune response (GO:0045824) | 2.66175085 |
| 96 | NIK/NF-kappaB signaling (GO:0038061) | 2.65538582 |
| 97 | positive regulation of B cell mediated immunity (GO:0002714) | 2.64871602 |
| 98 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.64871602 |
| 99 | response to interferon-alpha (GO:0035455) | 2.64073630 |
| 100 | maturation of SSU-rRNA (GO:0030490) | 2.62903663 |
| 101 | blood coagulation, intrinsic pathway (GO:0007597) | 2.60616829 |
| 102 | positive regulation of antigen processing and presentation (GO:0002579) | 2.59595975 |
| 103 | regulation of B cell differentiation (GO:0045577) | 2.59237142 |
| 104 | positive regulation of lamellipodium assembly (GO:0010592) | 2.58462620 |
| 105 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.57793296 |
| 106 | positive T cell selection (GO:0043368) | 2.57766469 |
| 107 | negative regulation of phagocytosis (GO:0050765) | 2.56960522 |
| 108 | positive regulation of granulocyte differentiation (GO:0030854) | 2.56868430 |
| 109 | cellular protein complex disassembly (GO:0043624) | 2.56594909 |
| 110 | response to type I interferon (GO:0034340) | 2.56114670 |
| 111 | lymphocyte chemotaxis (GO:0048247) | 2.56023433 |
| 112 | dendritic cell chemotaxis (GO:0002407) | 2.55663323 |
| 113 | type I interferon signaling pathway (GO:0060337) | 2.54743733 |
| 114 | cellular response to type I interferon (GO:0071357) | 2.54743733 |
| 115 | detection of external biotic stimulus (GO:0098581) | 2.54496423 |
| 116 | response to host immune response (GO:0052572) | 2.54101799 |
| 117 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.54101799 |
| 118 | regulation of cell killing (GO:0031341) | 2.53888623 |
| 119 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.53646476 |
| 120 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.52565111 |
| 121 | leukocyte aggregation (GO:0070486) | 2.51523392 |
| 122 | regulation of regulatory T cell differentiation (GO:0045589) | 2.51474884 |
| 123 | regulation of response to interferon-gamma (GO:0060330) | 2.51190042 |
| 124 | negative regulation of stress fiber assembly (GO:0051497) | 2.50701947 |
| 125 | T cell selection (GO:0045058) | 2.50373368 |
| 126 | regulation of leukocyte mediated immunity (GO:0002703) | 2.50221258 |
| 127 | actin nucleation (GO:0045010) | 2.48947827 |
| 128 | protein targeting to membrane (GO:0006612) | 2.48651934 |
| 129 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.46159791 |
| 130 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.44126699 |
| 131 | purine-containing compound salvage (GO:0043101) | 2.42795242 |
| 132 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.41947436 |
| 133 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.41237289 |
| 134 | cellular response to interferon-beta (GO:0035458) | 2.40867744 |
| 135 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.39660761 |
| 136 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.38320546 |
| 137 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.38175207 |
| 138 | B cell receptor signaling pathway (GO:0050853) | 2.37876267 |
| 139 | platelet dense granule organization (GO:0060155) | 2.37622530 |
| 140 | negative regulation of interleukin-12 production (GO:0032695) | 2.36519013 |
| 141 | pentose-phosphate shunt (GO:0006098) | 2.35880996 |
| 142 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.35567374 |
| 143 | immunoglobulin mediated immune response (GO:0016064) | 2.33786356 |
| 144 | T cell migration (GO:0072678) | 2.29056765 |
| 145 | translation (GO:0006412) | 2.29050169 |
| 146 | definitive hemopoiesis (GO:0060216) | 2.27768174 |
| 147 | regulation of necroptotic process (GO:0060544) | 2.27432456 |
| 148 | angiogenesis involved in wound healing (GO:0060055) | 2.27252376 |
| 149 | T cell apoptotic process (GO:0070231) | 2.26522455 |
| 150 | macrophage differentiation (GO:0030225) | 2.25696350 |
| 151 | regulation of erythrocyte differentiation (GO:0045646) | 2.24423337 |
| 152 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.24335011 |
| 153 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.24280863 |
| 154 | B cell mediated immunity (GO:0019724) | 2.24104152 |
| 155 | endosome to pigment granule transport (GO:0043485) | 2.23045948 |
| 156 | endosome to melanosome transport (GO:0035646) | 2.23045948 |
| 157 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.22574055 |
| 158 | platelet aggregation (GO:0070527) | 2.21973838 |
| 159 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.21505404 |
| 160 | negative T cell selection (GO:0043383) | 2.21443704 |
| 161 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.20971319 |
| 162 | negative thymic T cell selection (GO:0045060) | 2.20887296 |
| 163 | protein complex disassembly (GO:0043241) | 2.20305600 |
| 164 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.18595345 |
| 165 | cellular response to zinc ion (GO:0071294) | 2.18505013 |
| 166 | mast cell activation (GO:0045576) | 2.18343564 |
| 167 | purine nucleotide salvage (GO:0032261) | 2.18221410 |
| 168 | mature B cell differentiation (GO:0002335) | 2.18028375 |
| 169 | proteasome assembly (GO:0043248) | 2.17896181 |
| 170 | positive regulation of lamellipodium organization (GO:1902745) | 2.17350274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.34038873 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.00091016 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.66236351 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.58893227 |
| 5 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.51809765 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.41751289 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.37266678 |
| 8 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32668974 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.28267622 |
| 10 | GATA1_19941826_ChIP-Seq_K562_Human | 2.25844167 |
| 11 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.25491566 |
| 12 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22056633 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.19039925 |
| 14 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18125571 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.17834621 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.14848773 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.10642327 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06492100 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.05641893 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.99393795 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.94317210 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.90719914 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88864323 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.86848047 |
| 25 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.86405660 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.85818804 |
| 27 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.83883139 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81990675 |
| 29 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79870153 |
| 30 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.79590699 |
| 31 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79516901 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.74062591 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.70938877 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.70518150 |
| 35 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.69849245 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68916225 |
| 37 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67549965 |
| 38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.66517622 |
| 39 | MYB_26560356_Chip-Seq_TH2_Human | 1.65912638 |
| 40 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.64874284 |
| 41 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.63205614 |
| 42 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.62846356 |
| 43 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.62788059 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59734155 |
| 45 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.59035385 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58928651 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57680813 |
| 48 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.57589550 |
| 49 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57050334 |
| 50 | GATA2_19941826_ChIP-Seq_K562_Human | 1.56015697 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.52984843 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51713794 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49866233 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49591575 |
| 55 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.49056855 |
| 56 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48844247 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.48755977 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48364308 |
| 59 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.47057588 |
| 60 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.46832686 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45937227 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45081698 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44182452 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44158288 |
| 65 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.43470600 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.43275528 |
| 67 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42537886 |
| 68 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.42495489 |
| 69 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.38495945 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.37348093 |
| 71 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.37286535 |
| 72 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.36263560 |
| 73 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35989316 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.34682699 |
| 75 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.33316033 |
| 76 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.32438101 |
| 77 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32380025 |
| 78 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31278916 |
| 79 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.30991512 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30835713 |
| 81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30011248 |
| 82 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29724577 |
| 83 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28835298 |
| 84 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26457955 |
| 85 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.26429258 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25582454 |
| 87 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25527668 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25139661 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 1.23739542 |
| 90 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22375306 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21629993 |
| 92 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21488380 |
| 93 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.21009355 |
| 94 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20474531 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20233091 |
| 96 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.19183483 |
| 97 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.19135394 |
| 98 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18963265 |
| 99 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.17971415 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17560974 |
| 101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16615711 |
| 102 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16478490 |
| 103 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16363444 |
| 104 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16161786 |
| 105 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15860208 |
| 106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15468610 |
| 107 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15148911 |
| 108 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.14601105 |
| 109 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14260548 |
| 110 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13279573 |
| 111 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13128450 |
| 112 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12939217 |
| 113 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12395605 |
| 114 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11719033 |
| 115 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11164310 |
| 116 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11134158 |
| 117 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09144610 |
| 118 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07772493 |
| 119 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07730237 |
| 120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07328253 |
| 121 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.05520106 |
| 122 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03246880 |
| 123 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02610886 |
| 124 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01975751 |
| 125 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01818324 |
| 126 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01629973 |
| 127 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00507715 |
| 128 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00492163 |
| 129 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00274868 |
| 130 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99457613 |
| 131 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99361173 |
| 132 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98668877 |
| 133 | P300_27268052_Chip-Seq_Bcells_Human | 0.92430688 |
| 134 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91876258 |
| 135 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.87140174 |
| 136 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86676583 |
| 137 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84096325 |
| 138 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84034260 |
| 139 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82782634 |
| 140 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81459898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000685_abnormal_immune_system | 2.73115366 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.68468763 |
| 3 | MP0002396_abnormal_hematopoietic_system | 2.64889703 |
| 4 | MP0003763_abnormal_thymus_physiology | 2.58928105 |
| 5 | MP0003724_increased_susceptibility_to | 2.48900914 |
| 6 | MP0005671_abnormal_response_to | 2.41199721 |
| 7 | MP0006054_spinal_hemorrhage | 2.34527396 |
| 8 | MP0003436_decreased_susceptibility_to | 2.29021748 |
| 9 | MP0009785_altered_susceptibility_to | 2.21950447 |
| 10 | MP0008004_abnormal_stomach_pH | 2.17812676 |
| 11 | MP0009333_abnormal_splenocyte_physiolog | 2.05558863 |
| 12 | MP0005464_abnormal_platelet_physiology | 1.99194923 |
| 13 | MP0001800_abnormal_humoral_immune | 1.98886446 |
| 14 | MP0005000_abnormal_immune_tolerance | 1.97273304 |
| 15 | MP0005397_hematopoietic_system_phenotyp | 1.95597567 |
| 16 | MP0001545_abnormal_hematopoietic_system | 1.95597567 |
| 17 | MP0005025_abnormal_response_to | 1.95386098 |
| 18 | MP0002723_abnormal_immune_serum | 1.90471084 |
| 19 | MP0002420_abnormal_adaptive_immunity | 1.89009885 |
| 20 | MP0002398_abnormal_bone_marrow | 1.88789346 |
| 21 | MP0002452_abnormal_antigen_presenting | 1.86903739 |
| 22 | MP0001819_abnormal_immune_cell | 1.86567522 |
| 23 | MP0004808_abnormal_hematopoietic_stem | 1.82138170 |
| 24 | MP0005387_immune_system_phenotype | 1.78450014 |
| 25 | MP0001790_abnormal_immune_system | 1.78450014 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.77174813 |
| 27 | MP0002419_abnormal_innate_immunity | 1.76136882 |
| 28 | MP0002405_respiratory_system_inflammati | 1.74072570 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.73674348 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.72601592 |
| 31 | MP0002722_abnormal_immune_system | 1.68523676 |
| 32 | MP0009840_abnormal_foam_cell | 1.67604307 |
| 33 | MP0000716_abnormal_immune_system | 1.64858165 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.64836519 |
| 35 | MP0010368_abnormal_lymphatic_system | 1.64176008 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.60181356 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.57723489 |
| 38 | MP0003693_abnormal_embryo_hatching | 1.56418328 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.55148231 |
| 40 | MP0002429_abnormal_blood_cell | 1.54482372 |
| 41 | MP0000490_abnormal_crypts_of | 1.53979257 |
| 42 | MP0003279_aneurysm | 1.51818161 |
| 43 | MP0001853_heart_inflammation | 1.51463447 |
| 44 | MP0006082_CNS_inflammation | 1.51277893 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.48826722 |
| 46 | MP0000858_altered_metastatic_potential | 1.48159794 |
| 47 | MP0005023_abnormal_wound_healing | 1.47339290 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.45871586 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.44546805 |
| 50 | MP0003075_altered_response_to | 1.43519985 |
| 51 | MP0008469_abnormal_protein_level | 1.43232626 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.42200149 |
| 53 | MP0008438_abnormal_cutaneous_collagen | 1.41521051 |
| 54 | MP0003303_peritoneal_inflammation | 1.40655283 |
| 55 | MP0002933_joint_inflammation | 1.40312641 |
| 56 | MP0001873_stomach_inflammation | 1.40267754 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.39063087 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.37110984 |
| 59 | MP0000343_altered_response_to | 1.33933832 |
| 60 | MP0004947_skin_inflammation | 1.32782383 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.31920300 |
| 62 | MP0001851_eye_inflammation | 1.26777109 |
| 63 | MP0002139_abnormal_hepatobiliary_system | 1.25041465 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.23699962 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.22979536 |
| 66 | MP0003186_abnormal_redox_activity | 1.22346599 |
| 67 | MP0005083_abnormal_biliary_tract | 1.21575378 |
| 68 | MP0009278_abnormal_bone_marrow | 1.20345479 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.17480796 |
| 70 | MP0002006_tumorigenesis | 1.16119650 |
| 71 | MP0003866_abnormal_defecation | 1.11437918 |
| 72 | MP0008007_abnormal_cellular_replicative | 1.09688092 |
| 73 | MP0002019_abnormal_tumor_incidence | 1.07034005 |
| 74 | MP0001663_abnormal_digestive_system | 1.06211007 |
| 75 | MP0003828_pulmonary_edema | 1.03344914 |
| 76 | MP0004957_abnormal_blastocyst_morpholog | 1.02089524 |
| 77 | MP0003195_calcinosis | 1.02072685 |
| 78 | MP0005075_abnormal_melanosome_morpholog | 1.01251116 |
| 79 | MP0005365_abnormal_bile_salt | 1.00456938 |
| 80 | MP0000609_abnormal_liver_physiology | 0.97969526 |
| 81 | MP0003705_abnormal_hypodermis_morpholog | 0.97370127 |
| 82 | MP0000598_abnormal_liver_morphology | 0.95657533 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.95403353 |
| 84 | MP0009763_increased_sensitivity_to | 0.94875633 |
| 85 | MP0005166_decreased_susceptibility_to | 0.94729246 |
| 86 | MP0004130_abnormal_muscle_cell | 0.92974029 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.92291711 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.91307118 |
| 89 | MP0005220_abnormal_exocrine_pancreas | 0.89289006 |
| 90 | MP0004883_abnormal_blood_vessel | 0.87749007 |
| 91 | MP0003077_abnormal_cell_cycle | 0.86801575 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.86608597 |
| 93 | MP0001243_abnormal_dermal_layer | 0.86557716 |
| 94 | MP0008260_abnormal_autophagy | 0.84669462 |
| 95 | MP0001879_abnormal_lymphatic_vessel | 0.84507852 |
| 96 | MP0001542_abnormal_bone_strength | 0.84178955 |
| 97 | MP0005085_abnormal_gallbladder_physiolo | 0.82078459 |
| 98 | MP0001986_abnormal_taste_sensitivity | 0.82001665 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.81182051 |
| 100 | MP0000249_abnormal_blood_vessel | 0.81093836 |
| 101 | MP0005310_abnormal_salivary_gland | 0.80192832 |
| 102 | MP0010329_abnormal_lipoprotein_level | 0.79201286 |
| 103 | MP0005390_skeleton_phenotype | 0.79034033 |
| 104 | MP0002138_abnormal_hepatobiliary_system | 0.78764032 |
| 105 | MP0005164_abnormal_response_to | 0.78278861 |
| 106 | MP0000013_abnormal_adipose_tissue | 0.78278007 |
| 107 | MP0002132_abnormal_respiratory_system | 0.77694819 |
| 108 | MP0003795_abnormal_bone_structure | 0.77552793 |
| 109 | MP0001958_emphysema | 0.77153464 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.76806126 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.76144239 |
| 112 | MP0000358_abnormal_cell_content/ | 0.75948713 |
| 113 | MP0005451_abnormal_body_composition | 0.75048035 |
| 114 | MP0003448_altered_tumor_morphology | 0.73113790 |
| 115 | MP0003183_abnormal_peptide_metabolism | 0.72414354 |
| 116 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72393120 |
| 117 | MP0006036_abnormal_mitochondrial_physio | 0.72098443 |
| 118 | MP0005670_abnormal_white_adipose | 0.71882672 |
| 119 | MP0000604_amyloidosis | 0.71351874 |
| 120 | MP0000477_abnormal_intestine_morphology | 0.70938128 |
| 121 | MP0005165_increased_susceptibility_to | 0.70590979 |
| 122 | MP0009764_decreased_sensitivity_to | 0.70362018 |
| 123 | MP0004510_myositis | 0.69948081 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.67154222 |
| 125 | MP0008874_decreased_physiological_sensi | 0.66890404 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.66609163 |
| 127 | MP0003045_fibrosis | 0.65821897 |
| 128 | MP0002118_abnormal_lipid_homeostasis | 0.65022501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal platelet volume (HP:0011876) | 4.63656083 |
| 2 | Menorrhagia (HP:0000132) | 4.58605599 |
| 3 | Increased mean platelet volume (HP:0011877) | 4.39552351 |
| 4 | Stomatitis (HP:0010280) | 4.35412497 |
| 5 | Increased IgM level (HP:0003496) | 4.23435851 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.03283700 |
| 7 | Abnormality of the nasal mucosa (HP:0000433) | 3.81535271 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 3.73864952 |
| 9 | Obstructive lung disease (HP:0006536) | 3.73864952 |
| 10 | Thrombocytosis (HP:0001894) | 3.72493444 |
| 11 | IgM deficiency (HP:0002850) | 3.70922971 |
| 12 | Encephalitis (HP:0002383) | 3.52779747 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.46492122 |
| 14 | Spontaneous hematomas (HP:0007420) | 3.41934046 |
| 15 | Autoimmune hemolytic anemia (HP:0001890) | 3.40046680 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.23119275 |
| 17 | Optic neuritis (HP:0100653) | 3.23119275 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 3.19923303 |
| 19 | Petechiae (HP:0000967) | 3.16794936 |
| 20 | Myositis (HP:0100614) | 3.13538004 |
| 21 | Abnormality of iron homeostasis (HP:0011031) | 3.12551581 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 3.03443916 |
| 23 | Chronic otitis media (HP:0000389) | 3.02375063 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 2.93129099 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 2.92962890 |
| 26 | Nasal polyposis (HP:0100582) | 2.91342995 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.87126424 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.87126424 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 2.87126424 |
| 30 | Recurrent bronchitis (HP:0002837) | 2.86774722 |
| 31 | Leukocytosis (HP:0001974) | 2.86359768 |
| 32 | Abnormal number of erythroid precursors (HP:0012131) | 2.83293268 |
| 33 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.81439360 |
| 34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.79844184 |
| 35 | Protrusio acetabuli (HP:0003179) | 2.79347239 |
| 36 | Aplastic anemia (HP:0001915) | 2.78177467 |
| 37 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.78003049 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 2.76985171 |
| 39 | Epistaxis (HP:0000421) | 2.73127599 |
| 40 | Abnormality of T cells (HP:0002843) | 2.72064056 |
| 41 | Eczematoid dermatitis (HP:0000976) | 2.68277750 |
| 42 | Prolonged bleeding time (HP:0003010) | 2.65059511 |
| 43 | Hypochromic anemia (HP:0001931) | 2.64011607 |
| 44 | Granulocytopenia (HP:0001913) | 2.57251710 |
| 45 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.55634056 |
| 46 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.55634056 |
| 47 | Abnormal protein glycosylation (HP:0012346) | 2.55634056 |
| 48 | Abnormal glycosylation (HP:0012345) | 2.55634056 |
| 49 | Urticaria (HP:0001025) | 2.54048197 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.53729286 |
| 51 | Chest pain (HP:0100749) | 2.52628833 |
| 52 | Hematochezia (HP:0002573) | 2.51453737 |
| 53 | Type I transferrin isoform profile (HP:0003642) | 2.48107431 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.47635907 |
| 55 | Dysostosis multiplex (HP:0000943) | 2.47605678 |
| 56 | Microcytic anemia (HP:0001935) | 2.47524041 |
| 57 | Eosinophilia (HP:0001880) | 2.47385636 |
| 58 | Vertebral compression fractures (HP:0002953) | 2.46512777 |
| 59 | Polycythemia (HP:0001901) | 2.45198953 |
| 60 | Recurrent viral infections (HP:0004429) | 2.45040734 |
| 61 | Recurrent abscess formation (HP:0002722) | 2.44321268 |
| 62 | Pulmonary embolism (HP:0002204) | 2.41749019 |
| 63 | Gastrointestinal inflammation (HP:0004386) | 2.39618005 |
| 64 | Agammaglobulinemia (HP:0004432) | 2.39514303 |
| 65 | Abnormal platelet function (HP:0011869) | 2.38445935 |
| 66 | Impaired platelet aggregation (HP:0003540) | 2.38445935 |
| 67 | Hepatosplenomegaly (HP:0001433) | 2.34665720 |
| 68 | Nonimmune hydrops fetalis (HP:0001790) | 2.34507419 |
| 69 | Joint stiffness (HP:0001387) | 2.34431544 |
| 70 | Mucopolysacchariduria (HP:0008155) | 2.32083105 |
| 71 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.32083105 |
| 72 | Hypochromic microcytic anemia (HP:0004840) | 2.27619351 |
| 73 | Recurrent fungal infections (HP:0002841) | 2.27560263 |
| 74 | Microretrognathia (HP:0000308) | 2.26943466 |
| 75 | Anorexia (HP:0002039) | 2.26648822 |
| 76 | Inflammation of the large intestine (HP:0002037) | 2.26333999 |
| 77 | Keratoconjunctivitis sicca (HP:0001097) | 2.25651202 |
| 78 | Pulmonary infiltrates (HP:0002113) | 2.24940860 |
| 79 | Poikilocytosis (HP:0004447) | 2.24660679 |
| 80 | Thrombophlebitis (HP:0004418) | 2.21732215 |
| 81 | Cellulitis (HP:0100658) | 2.21546708 |
| 82 | Joint hemorrhage (HP:0005261) | 2.21152070 |
| 83 | Hypergammaglobulinemia (HP:0010702) | 2.21128476 |
| 84 | Beaking of vertebral bodies (HP:0004568) | 2.21033934 |
| 85 | Pustule (HP:0200039) | 2.20526267 |
| 86 | Episodic fever (HP:0001954) | 2.19863717 |
| 87 | Abnormality of the prostate (HP:0008775) | 2.19716430 |
| 88 | T lymphocytopenia (HP:0005403) | 2.18752628 |
| 89 | Reticulocytopenia (HP:0001896) | 2.17798917 |
| 90 | Cervical subluxation (HP:0003308) | 2.16102196 |
| 91 | Vertigo (HP:0002321) | 2.14282892 |
| 92 | Abnormality of eosinophils (HP:0001879) | 2.14274532 |
| 93 | Abnormality of T cell number (HP:0011839) | 2.13536575 |
| 94 | Interstitial pulmonary disease (HP:0006530) | 2.12919200 |
| 95 | Joint swelling (HP:0001386) | 2.11105326 |
| 96 | Panhypogammaglobulinemia (HP:0003139) | 2.10704471 |
| 97 | Keratoconjunctivitis (HP:0001096) | 2.09458277 |
| 98 | Colitis (HP:0002583) | 2.09304438 |
| 99 | Bruising susceptibility (HP:0000978) | 2.08492547 |
| 100 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.07547338 |
| 101 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.07547338 |
| 102 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06166620 |
| 103 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06166620 |
| 104 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06166620 |
| 105 | Orchitis (HP:0100796) | 2.05430390 |
| 106 | Hypertensive crisis (HP:0100735) | 2.04885714 |
| 107 | Hypoproteinemia (HP:0003075) | 2.03945870 |
| 108 | Acute hepatic failure (HP:0006554) | 2.02453728 |
| 109 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.01209829 |
| 110 | Hypoglycemic coma (HP:0001325) | 2.00944802 |
| 111 | Lymphopenia (HP:0001888) | 1.99528899 |
| 112 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98767567 |
| 113 | Generalized aminoaciduria (HP:0002909) | 1.98432897 |
| 114 | Myocardial infarction (HP:0001658) | 1.97549705 |
| 115 | Purpura (HP:0000979) | 1.96550661 |
| 116 | Increased serum ferritin (HP:0003281) | 1.95718357 |
| 117 | Pallor (HP:0000980) | 1.93990978 |
| 118 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93632796 |
| 119 | Paralysis (HP:0003470) | 1.93579962 |
| 120 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.92540524 |
| 121 | Hypertriglyceridemia (HP:0002155) | 1.90742933 |
| 122 | Entropion (HP:0000621) | 1.90711443 |
| 123 | Autoimmune thrombocytopenia (HP:0001973) | 1.90072081 |
| 124 | Increased cerebral lipofuscin (HP:0011813) | 1.89671425 |
| 125 | Abnormality of macrophages (HP:0004311) | 1.89469616 |
| 126 | Gingivitis (HP:0000230) | 1.88794158 |
| 127 | Abnormality of the intrinsic pathway (HP:0010989) | 1.88539512 |
| 128 | Recurrent bacterial skin infections (HP:0005406) | 1.87777334 |
| 129 | Gangrene (HP:0100758) | 1.87117310 |
| 130 | Recurrent cutaneous fungal infections (HP:0011370) | 1.86341333 |
| 131 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.86341333 |
| 132 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.85607103 |
| 133 | Biconcave vertebral bodies (HP:0004586) | 1.85295169 |
| 134 | Recurrent skin infections (HP:0001581) | 1.84097231 |
| 135 | Cerebral aneurysm (HP:0004944) | 1.83601840 |
| 136 | Fatigue (HP:0012378) | 1.83573559 |
| 137 | Meningitis (HP:0001287) | 1.81245215 |
| 138 | IgG deficiency (HP:0004315) | 1.79804895 |
| 139 | Emphysema (HP:0002097) | 1.78464605 |
| 140 | Hemoptysis (HP:0002105) | 1.77743206 |
| 141 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.75390559 |
| 142 | Broad face (HP:0000283) | 1.75150601 |
| 143 | Multiple enchondromatosis (HP:0005701) | 1.74946534 |
| 144 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.74777636 |
| 145 | Late onset (HP:0003584) | 1.74594297 |
| 146 | Abnormality of the common coagulation pathway (HP:0010990) | 1.73539519 |
| 147 | Gingival bleeding (HP:0000225) | 1.70052732 |
| 148 | Thoracic kyphosis (HP:0002942) | 1.68261465 |
| 149 | Poikiloderma (HP:0001029) | 1.67391824 |
| 150 | Vasculitis (HP:0002633) | 1.67286683 |
| 151 | Progressive neurologic deterioration (HP:0002344) | 1.66664054 |
| 152 | Arterial thrombosis (HP:0004420) | 1.66485659 |
| 153 | Increased IgE level (HP:0003212) | 1.66430017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.58142591 |
| 2 | ERN1 | 3.38225707 |
| 3 | TGFBR2 | 3.34534929 |
| 4 | KDR | 3.34237168 |
| 5 | MAP4K1 | 3.32287707 |
| 6 | TLK1 | 3.26821894 |
| 7 | NME2 | 3.23512817 |
| 8 | FES | 2.93162102 |
| 9 | TGFBR1 | 2.66234537 |
| 10 | ZAP70 | 2.37759077 |
| 11 | FLT3 | 2.09018753 |
| 12 | JAK3 | 2.08767072 |
| 13 | KIT | 1.96549749 |
| 14 | MAP2K3 | 1.95269986 |
| 15 | TRIB3 | 1.93200599 |
| 16 | TBK1 | 1.87877458 |
| 17 | RPS6KA4 | 1.83975518 |
| 18 | PIM2 | 1.83948977 |
| 19 | TIE1 | 1.80957813 |
| 20 | TXK | 1.79018911 |
| 21 | EEF2K | 1.74325158 |
| 22 | TYK2 | 1.72966372 |
| 23 | STK16 | 1.72141102 |
| 24 | TESK2 | 1.69037326 |
| 25 | TEC | 1.67415548 |
| 26 | BTK | 1.64702699 |
| 27 | PKN2 | 1.64527689 |
| 28 | BCKDK | 1.64412878 |
| 29 | LRRK2 | 1.60653143 |
| 30 | TAOK2 | 1.59663533 |
| 31 | BUB1 | 1.58775865 |
| 32 | ZAK | 1.56882848 |
| 33 | MAPKAPK3 | 1.52399303 |
| 34 | SCYL2 | 1.51064286 |
| 35 | STK10 | 1.50942500 |
| 36 | FGFR4 | 1.48181308 |
| 37 | IKBKE | 1.43224382 |
| 38 | BLK | 1.41770025 |
| 39 | MAP3K11 | 1.40061160 |
| 40 | BMX | 1.35940197 |
| 41 | CSF1R | 1.33416326 |
| 42 | PASK | 1.32854270 |
| 43 | MAP3K13 | 1.26904809 |
| 44 | ITK | 1.25386041 |
| 45 | BMPR2 | 1.23143257 |
| 46 | PRPF4B | 1.23071376 |
| 47 | GRK6 | 1.17856859 |
| 48 | MAP3K3 | 1.14928001 |
| 49 | FGR | 1.13040699 |
| 50 | MAP3K10 | 1.11797803 |
| 51 | IRAK3 | 1.11540910 |
| 52 | ACVR1B | 1.07329043 |
| 53 | EIF2AK3 | 1.05211331 |
| 54 | MARK3 | 1.04251791 |
| 55 | PAK4 | 1.03500227 |
| 56 | PRKCQ | 1.01569130 |
| 57 | MAPK15 | 1.00572970 |
| 58 | GRK7 | 0.97525473 |
| 59 | NLK | 0.96575090 |
| 60 | SYK | 0.95099455 |
| 61 | JAK1 | 0.92580062 |
| 62 | MAP3K1 | 0.90896025 |
| 63 | LCK | 0.90075825 |
| 64 | MAPK12 | 0.89394313 |
| 65 | MAP3K5 | 0.88830148 |
| 66 | IKBKB | 0.88505325 |
| 67 | MST4 | 0.87791585 |
| 68 | TAOK3 | 0.87086735 |
| 69 | RPS6KB2 | 0.86999887 |
| 70 | CSK | 0.86426202 |
| 71 | PTK2B | 0.86339537 |
| 72 | EIF2AK1 | 0.85665652 |
| 73 | PIM1 | 0.83655892 |
| 74 | TTN | 0.81368055 |
| 75 | WEE1 | 0.81053745 |
| 76 | MAP3K6 | 0.80854531 |
| 77 | IRAK4 | 0.80052588 |
| 78 | TESK1 | 0.77504599 |
| 79 | LYN | 0.74893237 |
| 80 | PRKG2 | 0.74412339 |
| 81 | HCK | 0.73426101 |
| 82 | MUSK | 0.72951893 |
| 83 | DYRK3 | 0.69636825 |
| 84 | MAP3K14 | 0.68405543 |
| 85 | PDK1 | 0.67573653 |
| 86 | MAP3K8 | 0.65130233 |
| 87 | PINK1 | 0.64539548 |
| 88 | CAMKK2 | 0.62028888 |
| 89 | PIK3CG | 0.61879867 |
| 90 | IRAK1 | 0.61713354 |
| 91 | VRK1 | 0.61389374 |
| 92 | CDK4 | 0.60008152 |
| 93 | NEK2 | 0.58504369 |
| 94 | PAK1 | 0.58411420 |
| 95 | BRSK2 | 0.56712707 |
| 96 | CDK7 | 0.56564335 |
| 97 | EPHB1 | 0.55897569 |
| 98 | MATK | 0.55671006 |
| 99 | JAK2 | 0.54651725 |
| 100 | HIPK2 | 0.52953127 |
| 101 | PTK6 | 0.50587638 |
| 102 | MOS | 0.49730056 |
| 103 | NUAK1 | 0.48267653 |
| 104 | RAF1 | 0.48239680 |
| 105 | ILK | 0.47954666 |
| 106 | MAP3K12 | 0.47176602 |
| 107 | MYLK | 0.46720541 |
| 108 | ADRBK1 | 0.46517225 |
| 109 | STK4 | 0.45553646 |
| 110 | ARAF | 0.44434370 |
| 111 | MAPK11 | 0.43961122 |
| 112 | CDK19 | 0.42930318 |
| 113 | GRK5 | 0.41017807 |
| 114 | MAP2K6 | 0.40876100 |
| 115 | EPHA2 | 0.39404662 |
| 116 | ADRBK2 | 0.38270482 |
| 117 | ABL1 | 0.38239441 |
| 118 | RIPK1 | 0.38237879 |
| 119 | FYN | 0.37946057 |
| 120 | PRKCD | 0.37884432 |
| 121 | MAP2K2 | 0.37123843 |
| 122 | SIK3 | 0.37102849 |
| 123 | IGF1R | 0.36202823 |
| 124 | MAPKAPK2 | 0.35405965 |
| 125 | CHUK | 0.35229503 |
| 126 | STK24 | 0.35149031 |
| 127 | RPS6KA6 | 0.34900050 |
| 128 | TRPM7 | 0.34782726 |
| 129 | PTK2 | 0.34572592 |
| 130 | TAOK1 | 0.33655089 |
| 131 | PDPK1 | 0.33402275 |
| 132 | PAK2 | 0.33033520 |
| 133 | TNK2 | 0.31004505 |
| 134 | RPS6KA5 | 0.29787302 |
| 135 | TSSK6 | 0.29460674 |
| 136 | SIK1 | 0.29447089 |
| 137 | MAPK7 | 0.29271703 |
| 138 | INSR | 0.27784690 |
| 139 | RET | 0.27458209 |
| 140 | PIK3CA | 0.21751502 |
| 141 | PRKD1 | 0.21667866 |
| 142 | PRKACG | 0.21299333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.69127186 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.19593025 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.03512065 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.82689161 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.66550762 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.35864123 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.27350123 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.11993500 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.06149046 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.03648414 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 1.92175659 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 1.85802930 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.84016432 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.78314769 |
| 15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.74450726 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71323475 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 1.63825070 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.62139337 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.62018372 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.56108847 |
| 21 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.55384346 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.54852340 |
| 23 | Sulfur relay system_Homo sapiens_hsa04122 | 1.54098357 |
| 24 | Shigellosis_Homo sapiens_hsa05131 | 1.51223698 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.51105945 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50345686 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49138591 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.48673906 |
| 29 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.47702280 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45808992 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45262996 |
| 32 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.41190761 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.39006525 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.38850786 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.37486175 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.35096940 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34784678 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30208100 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29598425 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.29505879 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27362572 |
| 42 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.25118486 |
| 43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.21409779 |
| 44 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.18244341 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.17541677 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.16143930 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15193953 |
| 48 | Spliceosome_Homo sapiens_hsa03040 | 1.14688158 |
| 49 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.14048579 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13730265 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.11085367 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 1.10806000 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10096547 |
| 54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08168378 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 1.07005070 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.06657358 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 1.05394937 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99433253 |
| 59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98719082 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97776195 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95495697 |
| 62 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95438506 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95041684 |
| 64 | Malaria_Homo sapiens_hsa05144 | 0.94432377 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94340502 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93610979 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.93608942 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.93236559 |
| 69 | RNA polymerase_Homo sapiens_hsa03020 | 0.93205818 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89190214 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88785970 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.88227120 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86785842 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86018498 |
| 75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.85938307 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84999551 |
| 77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84017988 |
| 78 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.82592551 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81965382 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.80363605 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77503031 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.75619727 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.74014879 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73567599 |
| 85 | Homologous recombination_Homo sapiens_hsa03440 | 0.73344479 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72514334 |
| 87 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69936794 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69227552 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68758029 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65513794 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64785963 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64101661 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63669980 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63390230 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61853335 |
| 96 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61009580 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57987869 |
| 98 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57974873 |
| 99 | Tuberculosis_Homo sapiens_hsa05152 | 0.57958108 |
| 100 | RNA degradation_Homo sapiens_hsa03018 | 0.57215436 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57008266 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56878723 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56351931 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53621696 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.51783303 |
| 106 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.49827093 |
| 107 | Purine metabolism_Homo sapiens_hsa00230 | 0.49802626 |
| 108 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49431274 |
| 109 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48701566 |
| 110 | Cell cycle_Homo sapiens_hsa04110 | 0.48025507 |
| 111 | Salmonella infection_Homo sapiens_hsa05132 | 0.47189144 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46748900 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46727300 |
| 114 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46387195 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45989469 |
| 116 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45425799 |
| 117 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43807607 |
| 118 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41113625 |
| 119 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40860587 |
| 120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40506199 |
| 121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40456063 |
| 122 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40361298 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40158847 |
| 124 | Carbon metabolism_Homo sapiens_hsa01200 | 0.39551752 |
| 125 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.39414149 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39284897 |
| 127 | Allograft rejection_Homo sapiens_hsa05330 | 0.39181819 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39178592 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38733196 |
| 130 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37913759 |
| 131 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.35548782 |
| 132 | ABC transporters_Homo sapiens_hsa02010 | 0.35330162 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34944621 |
| 134 | Hepatitis C_Homo sapiens_hsa05160 | 0.34874019 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | 0.31446812 |
| 136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.22936061 |
| 137 | Peroxisome_Homo sapiens_hsa04146 | 0.21453793 |
| 138 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.20745253 |
| 139 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.20227299 |

